This activity has expired. Thank you for using WebBasedCME.com. Continue to check our activities page for additional online CME offerings.

CONTINUING EDUCATION DEMOGRAPHIC AND EVALUATION FORM - Type 2 Diabetes: Pathophysiologic Challenges, Incretin Solutions – Webcast

1. What is your profession? Check all that apply.
MD
DO
RN
NP
PA
CDE
Other

2. What is your specialty? Check all that apply.
Endocrinology
Primary Care
Other

3. Uncovering Pathophysiologic Challenges in Type 2 Diabetes: The Role of Incretin Hormones
Rating Scale: 1=Poor 2=Fair 3=Good 4=Very Good 5=Excellent

(A): Knowledge of subject

1     2     3     4     5    

(B): Presentation was orderly and understandable

1     2     3     4     5    

(C): Use of audiovisual and discussion were effective in helping me learn

1     2     3     4     5    

4. Addressing Pathophysiologic Challenges in Type 2 Diabetes: Clinical Research on Incretin-Based Therapies
Rating Scale: 1=Poor 2=Fair 3=Good 4=Very Good 5=Excellent

(A): Knowledge of subject

1     2     3     4     5    

(B): Presentation was orderly and understandable

1     2     3     4     5    

(C): Use of audiovisual and discussion were effective in helping me learn

1     2     3     4     5    

5. Please evaluate how well the following learning objectives were met:
Rating Scale: 1=Poor 2=Fair 3=Good 4=Very Good 5=Excellent

(A): Describe the multiple metabolic defects that occur in type 2 diabetes

1     2     3     4     5    

(B): Explain the concept of the incretin effect, and describe defects in incretin secretion and action that occur in type 2 diabetes

1     2     3     4     5    

(C): Summarize the effects of GLP-1 and GLP-1 receptor agonists on metabolism

1     2     3     4     5    

(D): Discuss the clinical efficacy and safety of incretin-based therapies for the treatment of type 2 diabetes

1     2     3     4     5    

6. Was all data reported objectively and with appropriate referencing?
Yes
No

7. Was the overall content of this educational activity presented objectively and free of bias?
Yes
No

8. If you answered “No” to question 6 or 7, please explain:

9. Was the subject matter relevant to your clinical practice?
Yes
No

10. Was the educational format an effective learning method?
Yes
No

11. If you answered “No” to question 9 or 10, please explain:

12. What one question remains unanswered after having participated in this activity?

13. Cite one new piece of information learned from this activity.

14. What related topics would you like to have offered as future CME activities?

15. What are your preferred learning methods? (Check as many as applicable)
Live conferences
CD-ROM
Print materials (eg, monographs)
Internet/Web-based
Other

16. How did you learn about this educational activity?
Caring for Diabetes Educational Forum Web site
E-mail
Other

17. Additional Comments:

18. CONTINUING EDUCATION CREDIT ATTESTATION
The Center for Accredited Healthcare Education designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

I certify that I completed this educational activity. The actual amount of time I spent in this activity was:
 hours  minutes (Not to exceed 1.5 credits.)

 Enter Your Full Name